Similar articles

• Latent and lytic Epstein-Barr virus replication strategies.

  Tsurumi T, Fujita M, Kudoh A. Tsurumi T, et al. Rev Med Virol. 2005 Jan-Feb;15(1):3-15. doi: 10.1002/rmv.441. Rev Med Virol. 2005. PMID: 15386591 Review.
• Human p32: a coactivator for Epstein-Barr virus nuclear antigen-1-mediated transcriptional activation and possible role in viral latent cycle DNA replication.

  Van Scoy S, Watakabe I, Krainer AR, Hearing J. Van Scoy S, et al. Virology. 2000 Sep 15;275(1):145-57. doi: 10.1006/viro.2000.0508. Virology. 2000. PMID: 11017796
• [Latency vs lytic cycle of Epstein-Barr virus: regulation of a viral gene expression is the clue].

  Gruffat H, Manet E, Sergeant A. Gruffat H, et al. Pathol Biol (Paris). 2004 Mar;52(2):63-5. doi: 10.1016/j.patbio.2003.10.004. Pathol Biol (Paris). 2004. PMID: 15001233 French. No abstract available.
• [Replication of Epstein-Barr virus and host cell response].

  Tsurumi T, Kudoh A. Tsurumi T, et al. Seikagaku. 2005 Sep;77(9):1180-4. Seikagaku. 2005. PMID: 16241005 Review. Japanese. No abstract available.
• Amplification of the Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 lytic origin of DNA replication is dependent upon a cis-acting AT-rich region and an ORF50 response element and the trans-acting factors ORF50 (K-Rta) and K8 (K-bZIP).

  AuCoin DP, Colletti KS, Cei SA, Papousková I, Tarrant M, Pari GS. AuCoin DP, et al. Virology. 2004 Jan 20;318(2):542-55. doi: 10.1016/j.virol.2003.10.016. Virology. 2004. PMID: 14972523